HEADER HYDROLASE/HYDROLASE INHIBITOR 01-NOV-99 1DAZ
TITLE STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF HIV-1
TITLE 2 PROTEASE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: HIV-1 PROTEASE (RETROPEPSIN);
COMPND 3 CHAIN: C, D;
COMPND 4 EC: 3.4.23.16;
COMPND 5 ENGINEERED: YES;
COMPND 6 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HUMAN IMMUNODEFICIENCY VIRUS 1;
SOURCE 3 ORGANISM_TAXID: 11676;
SOURCE 4 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 5 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS HIV-1 PROTEASE, HYDROLASE-HYDROLASE INHIBITOR COMPLEX, REDUCED
KEYWDS 2 PEPTIDE INHIBITOR
EXPDTA X-RAY DIFFRACTION
AUTHOR B.MAHALINGAM,J.M.LOUIS,C.C.REED,J.M.ADOMAT,J.KROUSE,Y.F.WANG,
AUTHOR 2 R.W.HARRISON,I.T.WEBER
REVDAT 7 13-MAR-24 1DAZ 1 COMPND SOURCE
REVDAT 6 07-FEB-24 1DAZ 1 REMARK
REVDAT 5 03-NOV-21 1DAZ 1 REMARK SEQADV SHEET
REVDAT 4 13-JUL-11 1DAZ 1 VERSN
REVDAT 3 24-FEB-09 1DAZ 1 VERSN
REVDAT 2 01-APR-03 1DAZ 1 JRNL
REVDAT 1 03-MAY-00 1DAZ 0
JRNL AUTH B.MAHALINGAM,J.M.LOUIS,C.C.REED,J.M.ADOMAT,J.KROUSE,
JRNL AUTH 2 Y.F.WANG,R.W.HARRISON,I.T.WEBER
JRNL TITL STRUCTURAL AND KINETIC ANALYSIS OF DRUG RESISTANT MUTANTS OF
JRNL TITL 2 HIV-1 PROTEASE.
JRNL REF EUR.J.BIOCHEM. V. 263 238 1999
JRNL REFN ISSN 0014-2956
JRNL PMID 10429209
JRNL DOI 10.1046/J.1432-1327.1999.00514.X
REMARK 2
REMARK 2 RESOLUTION. 1.55 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : X-PLOR 3.843
REMARK 3 AUTHORS : BRUNGER
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.55
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 8.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 1.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL
REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 NUMBER OF REFLECTIONS : 26752
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : FREE-R
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING SET) : 0.213
REMARK 3 FREE R VALUE : 0.256
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000
REMARK 3 FREE R VALUE TEST SET COUNT : 1847
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 8
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.55
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.62
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2942
REMARK 3 BIN R VALUE (WORKING SET) : 0.2669
REMARK 3 BIN FREE R VALUE : 0.2838
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 258
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 1510
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 59
REMARK 3 SOLVENT ATOMS : 141
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : NULL
REMARK 3 B22 (A**2) : NULL
REMARK 3 B33 (A**2) : NULL
REMARK 3 B12 (A**2) : NULL
REMARK 3 B13 (A**2) : NULL
REMARK 3 B23 (A**2) : NULL
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM SIGMAA (A) : NULL
REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL
REMARK 3 ESD FROM C-V SIGMAA (A) : NULL
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 1.320
REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL
REMARK 3 IMPROPER ANGLES (DEGREES) : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO
REMARK 3 PARAMETER FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 1DAZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-NOV-99.
REMARK 100 THE DEPOSITION ID IS D_1000009935.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 14-OCT-97
REMARK 200 TEMPERATURE (KELVIN) : 90
REMARK 200 PH : 5.6
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : NSLS
REMARK 200 BEAMLINE : X12B
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.9803
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27073
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.550
REMARK 200 RESOLUTION RANGE LOW (A) : 32.600
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.4
REMARK 200 DATA REDUNDANCY : 6.400
REMARK 200 R MERGE (I) : 0.05400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.6000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.55
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.61
REMARK 200 COMPLETENESS FOR SHELL (%) : 93.9
REMARK 200 DATA REDUNDANCY IN SHELL : 5.96
REMARK 200 R MERGE FOR SHELL (I) : 0.13300
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 37.65
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.97
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: CITRATE/PHOSPHATE BUFFER 0.05M, DTT
REMARK 280 10MM, DMSO 10%, SATURATED AMMONIUM SULPHATE 25-50%, PROTEIN 2-5
REMARK 280 MG/ML, PH 5.6, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 297K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X+1/2,-Y,Z+1/2
REMARK 290 3555 -X,Y+1/2,-Z+1/2
REMARK 290 4555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 25.61950
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.60750
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 29.09600
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 30.60750
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 25.61950
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 29.09600
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 600
REMARK 600 HETEROGEN
REMARK 600
REMARK 600 THERE ARE TWO OPPOSITE ORIENTATIONS OF THE PEPTIDE
REMARK 600 INHIBITOR 0Q4 WITH HALF OCCUPANCIES EACH.
REMARK 600
REMARK 600 THE INHIBITOR HAS A REDUCED PEPTIDE (-CH2-NH) INSTEAD
REMARK 600 OF THE NORMAL PEPTIDE LINK (-CO-NH).
REMARK 630
REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR
REMARK 630 MOLECULE NAME: N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L-
REMARK 630 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-GLUTAMYL-L-
REMARK 630 ALANYL-L-NORLEUCINAMIDE
REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 630
REMARK 630 M RES C SSSEQI
REMARK 630 0Q4 D 601
REMARK 630 SOURCE: NULL
REMARK 630 TAXONOMY: NULL
REMARK 630 SUBCOMP: ARG VAL DC0 GLU ALA NLE NH2
REMARK 630 DETAILS: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 0Q4 D 601
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 1A94 RELATED DB: PDB
REMARK 900 1A94 IS THE STRUCTURE OF THE HIV-1 PROTEASE WITH MUTATIONS Q7K,
REMARK 900 L33I, L63I, C67A, C95A, WHICH STABILIZE THE PROTEASE FROM
REMARK 900 AUTOPROTEOLYSIS, WHILE RETAINING ACTIVITY SIMILAR TO WILD TYPE HIV-
REMARK 900 1 PROTEASE. THIS MUTANT (K45I) ALSO HAS THE ABOVE MUTATIONS TO
REMARK 900 PREVENT AUTOPROTEOLYSIS.
DBREF 1DAZ C 1 99 UNP P03367 POL_HV1BR 500 598
DBREF 1DAZ D 101 199 UNP P03367 POL_HV1BR 500 598
SEQADV 1DAZ LYS C 7 UNP P03367 GLN 75 ENGINEERED MUTATION
SEQADV 1DAZ ILE C 33 UNP P03367 LEU 91 ENGINEERED MUTATION
SEQADV 1DAZ ILE C 45 UNP P03367 LYS 103 ENGINEERED MUTATION
SEQADV 1DAZ ILE C 63 UNP P03367 LEU 131 ENGINEERED MUTATION
SEQADV 1DAZ ALA C 67 UNP P03367 CYS 135 ENGINEERED MUTATION
SEQADV 1DAZ ALA C 95 UNP P03367 CYS 163 ENGINEERED MUTATION
SEQADV 1DAZ LYS D 107 UNP P03367 GLN 75 ENGINEERED MUTATION
SEQADV 1DAZ ILE D 133 UNP P03367 LEU 91 ENGINEERED MUTATION
SEQADV 1DAZ ILE D 145 UNP P03367 LYS 103 ENGINEERED MUTATION
SEQADV 1DAZ ILE D 163 UNP P03367 LEU 131 ENGINEERED MUTATION
SEQADV 1DAZ ALA D 167 UNP P03367 CYS 135 ENGINEERED MUTATION
SEQADV 1DAZ ALA D 195 UNP P03367 CYS 163 ENGINEERED MUTATION
SEQRES 1 C 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 C 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 C 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 C 99 GLY ARG TRP LYS PRO ILE MET ILE GLY GLY ILE GLY GLY
SEQRES 5 C 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 C 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 C 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 C 99 GLN ILE GLY ALA THR LEU ASN PHE
SEQRES 1 D 99 PRO GLN ILE THR LEU TRP LYS ARG PRO LEU VAL THR ILE
SEQRES 2 D 99 LYS ILE GLY GLY GLN LEU LYS GLU ALA LEU LEU ASP THR
SEQRES 3 D 99 GLY ALA ASP ASP THR VAL ILE GLU GLU MET SER LEU PRO
SEQRES 4 D 99 GLY ARG TRP LYS PRO ILE MET ILE GLY GLY ILE GLY GLY
SEQRES 5 D 99 PHE ILE LYS VAL ARG GLN TYR ASP GLN ILE ILE ILE GLU
SEQRES 6 D 99 ILE ALA GLY HIS LYS ALA ILE GLY THR VAL LEU VAL GLY
SEQRES 7 D 99 PRO THR PRO VAL ASN ILE ILE GLY ARG ASN LEU LEU THR
SEQRES 8 D 99 GLN ILE GLY ALA THR LEU ASN PHE
HET 0Q4 D 601 118
HETNAM 0Q4 N-[(2R)-2-({N~5~-[AMINO(IMINIO)METHYL]-L-ORNITHYL-L-
HETNAM 2 0Q4 VALYL}AMINO)-4-METHYLPENTYL]-L-PHENYLALANYL-L-ALPHA-
HETNAM 3 0Q4 GLUTAMYL-L-ALANYL-L-NORLEUCINAMIDE
HETSYN 0Q4 INHIBITOR ANALOGUES OF CA-P2
FORMUL 3 0Q4 C40 H70 N11 O8 1+
FORMUL 4 HOH *141(H2 O)
HELIX 1 1 GLY C 86 THR C 91 1 6
HELIX 2 2 GLY D 186 THR D 191 1 6
SHEET 1 A 4 GLN C 2 ILE C 3 0
SHEET 2 A 4 THR D 196 ASN D 198 -1 O LEU D 197 N ILE C 3
SHEET 3 A 4 THR C 96 ASN C 98 -1 N THR C 96 O ASN D 198
SHEET 4 A 4 GLN D 102 THR D 104 -1 N ILE D 103 O LEU C 97
SHEET 1 B 8 LYS C 43 GLY C 49 0
SHEET 2 B 8 GLY C 52 ILE C 66 -1 O GLY C 52 N GLY C 49
SHEET 3 B 8 HIS C 69 GLY C 78 -1 O HIS C 69 N ILE C 66
SHEET 4 B 8 VAL C 32 GLU C 34 1 N ILE C 33 O LEU C 76
SHEET 5 B 8 ILE C 84 ILE C 85 -1 N ILE C 84 O VAL C 32
SHEET 6 B 8 GLN C 18 LEU C 24 1 O LEU C 23 N ILE C 85
SHEET 7 B 8 LEU C 10 ILE C 15 -1 O VAL C 11 N ALA C 22
SHEET 8 B 8 GLY C 52 ILE C 66 -1 N GLU C 65 O LYS C 14
SHEET 1 C 8 TRP D 142 GLY D 149 0
SHEET 2 C 8 PHE D 153 ILE D 166 -1 N ILE D 154 O ILE D 147
SHEET 3 C 8 HIS D 169 VAL D 177 -1 O HIS D 169 N ILE D 166
SHEET 4 C 8 VAL D 132 ILE D 133 1 N ILE D 133 O LEU D 176
SHEET 5 C 8 ILE D 184 ILE D 185 -1 N ILE D 184 O VAL D 132
SHEET 6 C 8 GLN D 118 LEU D 124 1 O LEU D 123 N ILE D 185
SHEET 7 C 8 LEU D 110 ILE D 115 -1 N VAL D 111 O ALA D 122
SHEET 8 C 8 PHE D 153 ILE D 166 -1 N GLU D 165 O LYS D 114
SITE 1 AC1 41 TRP C 6 ARG C 8 LEU C 23 ASP C 25
SITE 2 AC1 41 GLY C 27 ALA C 28 ASP C 29 ASP C 30
SITE 3 AC1 41 VAL C 32 ILE C 45 MET C 46 ILE C 47
SITE 4 AC1 41 GLY C 48 GLY C 49 ILE C 50 PHE C 53
SITE 5 AC1 41 GLN C 58 PRO C 81 VAL C 82 ILE C 84
SITE 6 AC1 41 HOH D 14 HOH D 49 ARG D 108 LEU D 123
SITE 7 AC1 41 ASP D 125 GLY D 127 ASP D 129 ASP D 130
SITE 8 AC1 41 VAL D 132 MET D 146 ILE D 147 GLY D 148
SITE 9 AC1 41 GLY D 149 ILE D 150 PRO D 181 VAL D 182
SITE 10 AC1 41 ILE D 184 HOH D 261 HOH D 262 HOH D 263
SITE 11 AC1 41 HOH D 387
CRYST1 51.239 58.192 61.215 90.00 90.00 90.00 P 21 21 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.019516 0.000000 0.000000 0.00000
SCALE2 0.000000 0.017184 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016336 0.00000